5-Bromo-2,4-Dichloropyrimidine CAS 36082-50-5 Ịdị Ọcha>99.0% (GC) Palbociclib Intermediate Factory
Ruifu Chemical Supply Palbociclib metụtara Intermediates:
Palbociclib CAS 571190-30-2
5-Bromo-2,4-Dichloropyrimidine CAS 36082-50-5
5-Bromo-2-Chloro-N-Cyclopentylpyrimidin-4-Amine CAS 733039-20-8
tert-Butyl 4-(6-Nitropyridin-3-yl)piperazine-1-Carboxylate CAS 571189-16-7
tert-Butyl 4-(6-Amino-3-Pyridyl)piperazine-1-Carboxylate CAS 571188-59-5
6-Bromo-2-Chloro-8-Cyclopentyl-5-Methylpyrido-[2,3-d]pyrimidin-7(8H) -otu CAS 1016636-76-2
2-Chloro-8-Cyclopentyl-5-Methyl-8H-Pyrido[2,3-d]pyrimidin-7-otu CAS 1013916-37-4
Aha Chemical | 5-Bromo-2,4-Dichloropyrimidine |
Nọmba CAS | 36082-50-5 |
Nọmba CAT | RF-PI1852 |
Ọnọdụ Ahịa | N'ọkwa, Mpụta Ihe ruru Tọn |
Usoro ihe omimi | C4HBrCl2N2 |
Ibu molekụla | 227.87 |
Ebe esi nri | 128 ℃ / 15 mmHg (ọkụ) |
Njupụta | 1.781 g/mL na 25 ℃ (ọkụ) |
Ntụgharị uche | n20/D 1.603 (ọkụ) |
Solubility | Soluble na methanol |
Ụdị | Ruifu Chemical |
Ihe | Nkọwapụta |
Ọdịdị | Mmiri mmiri na-acha odo odo enweghị agba |
Ụzọ ịdị ọcha / nyocha | > 99.0% (GC) |
Ebe Na-agbaze | 29.0-30.0 ℃ |
Mmiri (nke Karl Fischer) | <0.50% |
2,4-Dichloropyrimidine | <0.50% (GC) |
Oke Otu adịghị ọcha | <0.50% (GC) |
Mgbakọta adịghị ọcha | <1.00% |
1 H NMR Spectrum | Nkwekọrịta na Ọdịdị |
Nlele ọkọlọtọ | Standardkpụrụ ụlọ ọrụ |
Ojiji | Ọkara nke Palbociclib (CAS: 571190-30-2) |
ngwugwu: Klas Fluorinated, 25kg/Drum, ma ọ bụ dị ka ndị ahịa chọrọ
Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ìhè na mmiri mmiri
Enwere ike iji 5-Bromo-2,4-Dichloropyrimidine (CAS: 36082-50-5) rụọ ọrụ dị ka mmalite reagent maka njikọ nke modulators dị mma maka ndị na-anabata GABAB (klas ọgwụ dị ka ogige) na pyridinepyrimidine analogues.Enwere ike iji 5-Bromo-2,4-Dichloropyrimidine mee ihe dị ka etiti nke Palbociclib (CAS: 571190-30-2).Palbociclib (nke a makwaara dị ka nọmba ogige PD-0332991) bụ ọgwụ nnwale maka ọgwụgwọ ọrịa kansa ara nke Pfizer na-emepụta.Palbociclib bụ onye na-egbochi nhọrọ nke kinase nke dabere na cyclin CDK4 na CDK6.